Source link : https://www.newshealth.biz/health-news/snfl-and-sgfap-predict-ms-disability-in-unique-ways/
COPENHAGEN — Serum glial fibrillary acidic protein (sGFAP) is quickly maturing as a biomarker to predict disability in patients with multiple sclerosis (MS), but it will add information to, not compete with, serum neurofilament light chain (sNFl) levels, according to multiple independent studies. The basic consensus is that “elevated sNFl levels predict inflammatory-associated worsening, while […]
Author : News Health
Publish date : 2024-10-07 05:51:35
Copyright for syndicated content belongs to the linked Source.